CPIX · Cumberland Pharmaceuticals Inc
$8.65
-0.32 (-3.57%)
At close · Aug 27
Market Cap
$133.80M
Shares
14.98M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-07 | 2026-06-30 | |
| 8-K | 2026-08-04 | — | |
| 8-K | 2026-07-13 | — | |
| 8-K | 2026-07-01 | 2026-06-29 | |
| 8-K | 2026-06-25 | 2026-06-24 | |
| 10-Q | 2026-05-08 | 2026-03-31 | |
| 8-K | 2026-05-05 | — | |
| 8-K | 2026-04-24 | 2026-04-21 | |
| 8-K | 2026-04-23 | 2026-04-22 | |
| 10-K | 2026-03-09 | 2025-12-31 | |
| DEF 14A | 2026-03-09 | 2025-12-31 | |
| 8-K | 2026-03-03 | — | |
| 8-K | 2026-02-04 | — | |
| 8-K | 2025-11-24 | 2025-11-18 | |
| 10-Q | 2025-11-07 | 2025-09-30 | |
| 8-K | 2025-11-04 | — | |
| 8-K | 2025-10-21 | — | |
| 10-Q | 2025-08-08 | 2025-06-30 | |
| 8-K | 2025-08-05 | — | |
| 10-Q | 2025-05-09 | 2025-03-31 | |
| 8-K | 2025-05-06 | — | |
| 8-K | 2025-04-28 | — | |
| 8-K | 2025-03-19 | — | |
| DEF 14A | 2025-03-10 | 2024-12-31 | |
| 10-K | 2025-03-07 | 2024-12-31 | |
| 8-K | 2025-03-04 | — | |
| 8-K | 2025-02-19 | — | |
| 8-K | 2025-02-14 | — | |
| 8-K | 2025-02-04 | — | |
| 8-K | 2024-12-09 | — | |
| 8-K | 2024-11-12 | 2024-11-06 | |
| 10-Q | 2024-11-08 | 2024-09-30 | |
| 8-K | 2024-11-07 | — | |
| 8-K | 2024-11-06 | — | |
| 8-K | 2024-11-04 | — | |
| 10-Q | 2024-08-09 | 2024-06-30 | |
| 8-K | 2024-08-06 | — | |
| 10-Q | 2024-05-10 | 2024-03-31 | |
| 8-K | 2024-05-07 | — | |
| 8-K | 2024-04-29 | — | |
| 8-K | 2024-03-20 | — | |
| 10-K | 2024-03-13 | 2023-12-31 | |
| DEF 14A | 2024-03-13 | 2023-12-31 | |
| 8-K | 2024-03-05 | — | |
| 10-Q | 2023-11-13 | 2023-09-30 | |
| 8-K | 2023-11-07 | — | |
| 8-K | 2023-10-13 | — | |
| 8-K | 2023-09-06 | 2023-09-05 | |
| 10-Q | 2023-08-11 | 2023-06-30 | |
| 8-K | 2023-08-08 | — |
Showing 1–50 of 120 filings
Key facts
CIK
1087294
CUSIP
230770109
13F (30d)
31 filings
31 filers
Visit website
Investor relations